Cite
APA Citation
Hageman, S., Dorresteijn, J., Bots, M., Asselbergs, F., Mosterd, A., Westerink, J., & Visseren, F. (n.d.). predicted lifetime therapy benefit guided treatment effectively reduces residual cardiovascular risk in patients with symptomatic atherosclerotic disease. European heart journal, 41, . http://access.bl.uk/ark:/81055/vdc_100117807355.0x000029